Research Article

Comparison of 3D Conformal Proton Therapy, Intensity-Modulated Proton Therapy, and Intensity-Modulated Photon Therapy for Retroperitoneal Sarcoma

Table 4

Dose to organs at risk.

Dmean to the liver (n = 8)Preop boost (n = 3)

IMXT0.94–24.6 Gy, mean 11.8 Gy12.0–24.6 Gy, mean 16.7 Gy
3D CPT1.1–20.9 Gy,1.2 mean 6.61 Gy ()
IMPT0.99–18.6 Gy, mean 5.73 Gy ()2.8–18.6 Gy, mean 9.2 Gy

Dmean to the stomach (n = 8)Preop boost (n = 3)
IMXT4.03–44.2 Gy, mean 15.4 Gy13.3–43.6 Gy, mean 28.4 Gy
3D CPT0–50.0 Gy, mean 11.8 Gy ()
IMPT0–36.5 Gy, mean 7.85 Gy ()3.5–35.2 Gy, mean 16.8 Gy

Dmean to the small bowel (n = 8)Preop boost (n = 4)
IMXT1.71–24.8 Gy, mean 13.4 Gy4–21.5 Gy, mean 11.4 Gy
3D CPT2.4–16.0 Gy, mean 7.13 Gy ()
IMPT0.82–12.3 Gy, mean 5.80 Gy ()0.68–7.6 Gy, mean 3.9 Gy